AnalystConsensusTarget lifts target to USD 7.33 for CareCloud stock

Published on 10/15/2026 at 21:59 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Q2 2026 revenue rose 16.00 percent to USD 31.90 million. CareCloud stock costs EUR 1.73 on October 15, 2026 at 9:50 p.m. CEST.

Targets and reporting dates

AnalystConsensusTarget moved its CareCloud estimate from USD 6.31 to USD 7.33 on September 15, 2026.
Second-quarter 2026 revenue increased 16.00 percent to USD 31.90 million.
CareCloud stock costs EUR 1.73 at Lang & Schwarz on October 15, 2026 at 9:50 p.m. CEST.
CareCloud will release third-quarter 2026 results on November 5, 2026.

CCLD, US14167R1005, Illustration mit AI erstellt.

AnalystConsensusTarget lifted its CareCloud estimate from USD 6.31 to USD 7.33 in an update shared on September 15, 2026, according to Simply Wall St. The estimate stands 277.84 percent above the USD 1.94 Nasdaq price at 3:56 p.m. ET on October 15, 2026. CareCloud stock was trading at EUR 1.73 at Lang & Schwarz on October 15, 2026 at 9:50 p.m. CEST.

Revenue growth reaches 16.00 percent

CareCloud generated USD 31.90 million of revenue in the second quarter of 2026, up 16.00 percent from USD 27.40 million in the second quarter of 2025, according to Benzinga. GAAP net income was USD 1.10 million, compared with USD 2.90 million in the year-earlier quarter. Adjusted EBITDA reached USD 5.90 million.

Stock stays near its yearly low

The EUR 1.73 Lang & Schwarz quote sits at the lower edge of the USD 1.73 to USD 3.81 52-week range reported for the Nasdaq listing as of October 15, 2026. CareCloud's market capitalization was USD 82.20 million, while its price-to-earnings ratio was 27.79. The Nasdaq quote had risen 9.32 percent to USD 1.94 at 3:56 p.m. ET on October 15, 2026.

November 5 brings the next results

CareCloud will publish results for the third quarter ended September 30, 2026 before the market opens on November 5, 2026, with a conference call scheduled for 8:30 a.m. ET, according to Business Insider. The date gives the target and the recent revenue trend a clear next checkpoint.

Comparison with peers

CareCloud (Nasdaq, USD): plus 9.32 percent, P/E 27.79, market capitalization USD 82.20 million
Evolent Health (NYSE, USD): plus 2.64 percent, P/E minus 1.07, market capitalization USD 546.10 million
Privia Health (Nasdaq, USD): plus 4.45 percent, P/E 104.26, market capitalization USD 2.90 billion

Price and market position

CareCloud's small-cap profile contrasts with the larger valuations of Evolent Health and Privia Health, while its 16.00 percent second-quarter revenue growth provides the latest operating measure for comparison. The estimate increase to USD 7.33 remains the most prominent valuation reference in recent coverage.

CareCloud stock was trading at EUR 1.73 at Lang & Schwarz on October 15, 2026 at 9:50 p.m. CEST. The further course of trading is shown by the continuously updated real-time quote of CareCloud stock.